A NOVEL study has shown that Glucagon-like peptide-1 (GLP-1) agonists, medications widely used for obesity and type 2 diabetes, may offer benefits for patients with hidradenitis suppurativa (HS), a chronic inflammatory skin condition often associated with obesity
If the State Health Plan Board continues to cover GLP-1 medications, the treasurer's office estimated that it would increase monthly premiums for everyone on the plan, not just users of the medication, by $48.50 per month
State officials say health equity the idea that all groups regardless of background deserve equal access to health care is one of the main reasons they are considering the coverage, but that they worry higher costs will put pressure on their Medicaid budgets, said KFF senior policy analyst Liz Williams, who co-authored the survey of state Medicaid program directors
That is an oversimplification that sets you up to waste time and money
Lets have a closer look at the FDA drug applications